Levetiracetam is used to treat epilepsy as it can help to prevent seizures from happening. It may also be referred to by its brand name Keppra®.
Levetiracetam is an epilepsy drug, NICE do not recommend it for treating brain tumours specifically.
Levetiracetam and brain tumours
It may be used in patients with brain tumours to manage seizures. Researchers have found this drug to be preferable for brain tumour patients compared to other anti-epileptic medications as it does not interact with other drugs the patients are likely to be taking.
Research involving levetiracetam
There has been some early studies into whether levetiracetam can increase the effectiveness of temozolomide which appear to have shown positive results. Further research is required to know whether this is effective.
Levetiracetam is an epilepsy drug, NICE do not recommend it for treating brain tumours specifically. You should speak to your healthcare team before taking new medications or making changes to your existing brain tumour treatment.
If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:
Support and Information Services
0808 800 0004 (free from landlines and mobiles)
Phone lines open Mon-Fri, 09:00-17:00
Research & Clinical Trials Information
You can also join our active online community - Join our online support groups.